• Date: 2025
  Title: Apixaban for Extended Treatment of Provoked Venous Thromboembolism
• Date: 2025
  Title: Impact of Time to Catheter-Based Therapy on Outcomes in Acute Pulmonary Embolism
• Date: 2025
  Title: Deficient FANCL Predisposes to Endothelial Damage: A New Therapeutic Target for Pulmonary Hypertension
• Date: 2025
  Title: Acute right ventricular failure: pathophysiology, aetiology, assessment, and management
• Date: 2025
  Title: Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension Results of an International Multicenter Prospective Registry.
• Date: 2025
  Title: Acute pulmonary embolism: a multimarker calculator to predict short-term outcomes
• Date: 2025
  Title: Extended treatment of venous thromboembolism with reduced-dose versus full-dose direct oral anticoagulants in patients at high risk of recurrence: a non-inferiority, multicentre, randomised, open-label, blinded endpoint trial.
• Date: 2025
  Title: Macitentan for Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Pulmonary Vascular Disease: Results of the SERENADE Randomized Clinical Trial and Open-Label Extension Study
• Date: 2025
  Title: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in CTEPH: Insights From the RACE trial
• Date: 2025
  Title: Large-bore Mechanical Thrombectomy Versus Catheter-directed Thrombolysis in the Management of Intermediate-risk Pulmonary Embolism: Primary Results of the PEERLESS Randomized Controlled Trial
• Date: 2025
  Title: Efficacy and Safety of Sotatercept Across Ranges of Cardiac Index in Patients with Pulmonary Arterial Hypertension: A Pooled Analysis of PULSAR and STELLAR. J Heart Lung Transplant.
• Date: 2025
  Title: Dual-layer dual-energy CT characterization of thrombus composition in acute pulmonary embolism and chronic thromboembolic pulmonary hypertension. Int J Cardiovasc Imaging
• Date: 2024
  Title: Is it time for a myocardial infarction approach to high- and intermediate-high-risk pulmonary embolism?
• Date: 2024
  Title: Risk stratification refinements with inclusion of haemodynamic variables at follow-up in patients with pulmonary arterial hypertension
• Date: 2024
  Title: Non-contrasted computed tomography (NCCT) based chronic thromboembolic pulmonary hypertension (CTEPH) automatic diagnosis using cascaded network with multiple instance learning
• Date: 2024
  Title: Pulmonary arterial hypertension treatment: an individual participant data network meta-analysis
• Date: 2024
  Title: Prospective multicenter international registry of ultrasound-facilitated catheter-directed thrombolysis in intermediate-high and high-risk pulmonary embolism (KNOCOUT PE)
• Date: 2024
  Title: Initial combination therapy with macitentan and tadalafil in patients with pulmonary arterial hypertension, with and without cardiac comorbidities
• Date: 2024
  Title: Ultrasound neuromodulation of an anti-inflammatory pathway at the spleen improves experimental pulmonary hypertension
• Date: 2024
  Title: Clinical, Functional, and Quality of Life Outcomes after Computer Assisted Vacuum Thrombectomy for Pulmonary Embolism: Interim Analysis of the STRIKE-PE Study
• Date: 2024
  Title: A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure.
• Date: 2024
  Title: D'Alto M et al. Right heart failure as a cause of pulmonary congestion in pulmonary arterial hypertension. Eur J Heart Fail.
• Date: 2024
  Title: Finochiaro S et al. Percutaneous interventions for pulmonary embolism
• Date: 2024
  Title: Gargani et al. exercise stress echocardiography of the right ventricle and pulmonary circulation
• Date: 2024
  Title: Overnight exposure to high altitude in pulmonary hypertension: adverse events and effect of oxygen therapy
• Date: 2024
  Title: Predictors of outcomes in mild pulmonary hypertension according to 2022 ESC/ERS Guidelines: the EVIDENCE-PAH UK study
• Date: 2024
  Title: Contemporary Management and Outcomes of Patients With High-Risk Pulmonary Embolism
• Date: 2023
  Title: Long-Term Effects of Sotatercept on Right Ventricular Function: Results From the PULSAR Study
• Date: 2023
  Title: Outcomes in High-Risk Pulmonary Embolism Patients Undergoing FlowTriever Mechanical Thrombectomy or Other Contemporary Therapies: Results From the FLAME Study
• Date: 2023
  Title: Left Ventricular Filling Pressure in Chronic Thromboembolic Pulmonary Hypertension
• Date: 2023
  Title: Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
• Date: 2023
  Title: Catheter-Directed Thrombolysis vs Anticoagulation in Patients With Acute Intermediate-High-risk Pulmonary Embolism: The CANARY Randomized Clinical Trial
• Date: 2023
  Title: Prognostic implications of atrial vs. ventricular functional tricuspid regurgitation
• Date: 2022
  Title: Milvexian for the prevention of venous thromboembolism
• Date: 2022
  Title: Safety and efficiency of diagnostic strategies for ruling out pulmonary embolism in clinically relevant patient subgroups : a systematic review and individual-patient data meta-analysis
• Date: 2022
  Title: Effect of antiplatelet therapy on survival and organ support-free days in critically ill patients with COVID-19: a randomized clinical trial
• Date: 2022
  Title: Determinants of altered left ventricular suction in pre-capillary pulmonary hypertension
• Date: 2021
  Title: Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort Study
• Date: 2021
  Title: The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study
• Date: 2021
  Title: COMPERA 2.0: A refined 4-strata risk assessment model for pulmonary arterial hypertension
• Date: 2021
  Title: Temporal trends in pulmonary arterial hypertension: Results from the COMPERA registry
• Date: 2021
  Title: Clinical features and survival in Takayasu's arteritis-associated pulmonary hypertension: a nationwide study
• Date: 2021
  Title: Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial
• Date: 2021
  Title: Association Between Initial Treatment Strategy and Long-term Survival in Pulmonary Arterial Hypertension
• Date: 2021
  Title: Characteristics and outcomes of patients with chronic thromboembolic pulmonary hypertension in the era of modern therapeutic approaches: data from the Polish multicenter registry (BNP-PL)
• Date: 2021
  Title: PH CARE COVID survey: an international patient survey on the care for pulmonary hypertension patients during the early phase of the COVID-19 pandemic
• Date: 2021
  Title: Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit The INSPIRATION Randomized Clinical Trial
• Date: 2021
  Title: Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review
• Date: 2021
  Title: Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave
• Date: 2021
  Title: Pulmonary hypertension in patients with chronic obstructive lung disease: results from COMPERA
• Date: 2020
  Title: Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial
• Date: 2020
  Title: One-Year Echocardiographic, Functional, and Quality of Life Outcomes After Ultrasound-Facilitated Catheter-Based Fibrinolysis for Pulmonary Embolism
• Date: 2020
  Title: EXPRESS: Rethinking COVID-19 ‘pneumonia’ – Is this primarily a vaso-occlusive disease, and can early anticoagulation save the ventilator famine?
• Date: 2020
  Title: COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
• Date: 2020
  Title: Diagnosis of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism
• Date: 2020
  Title: Care of patients with Pulmonary Arterial Hypertension during the Coronavirus (COVID-19) Pandemic
• Date: 2020
  Title: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
• Date: 2020
  Title: Systemic Consequences of Pulmonary Hypertension and Right-Sided Heart Failure
• Date: 2020
  Title: Early discharge and home treatment of patients with low-risk pulmonary embolismwith the oral factor Xa inhibitor rivaroxaban: an international multicentre single-armclinical trial
• Date: 2020
  Title: Familial pulmonary arterial hypertension by KDR heterozygous loss of function
• Date: 2019
  Title: Screening strategies for pulmonary arterial hypertension
• Date: 2019
  Title: Clinical outcomes of patients with pulmonary embolism versus deep vein thrombosis: From the COMMAND VTE Registry
• Date: 2019
  Title: 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT
• Date: 2019
  Title: Hospital volume and outcomes for acute pulmonary embolism: multinational population based cohort study
• Date: 2019
  Title: A Multicenter Trial of Vena Cava Filters in Severely Injured Patients
• Date: 2019
  Title: Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
• Date: 2019
  Title: Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial
• Date: 2019
  Title: Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany
• Date: 2019
  Title: Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension
• Date: 2019
  Title: Anatomy, Function, and Dysfunction of the Right Ventricle
• Date: 2019
  Title: Balloon pulmonary angioplasty for the treatment of residual or recurrent pulmonary hypertension after pulmonary endarterectomy
• Date: 2019
  Title: Proposed new pulmonary hypertension definition: is 4 mm(Hg) worth re-writing medical textbooks?
• Date: 2019
  Title: The new haemodynamic definition of pulmonary hypertension: evidence prevails, finally!
• Date: 2018
  Title: Clinical and Hemodynamic Factors in Predicting Response to Fluid Challenge during Right Heart Catheterization
• Date: 2018
  Title: Discordance between Imaging Modalities in the Evaluation of Chronic Thromboembolic Pulmonary Hypertension: A Combined Experience from Two Academic Medical Centers
• Date: 2018
  Title: Balloon pulmonary angioplasty for the treatment of residual or recurrent pulmonary hypertension after pulmonary endarterectomy
• Date: 2018
  Title: Value of lung perfusion scintigraphy in patients with idiopathic pulmonary arterial hypertension: a patchy pattern to consider
• Date: 2018
  Title: Hemodynamics of the diastolic pressure gradients in acute heart failure: Implications for the diagnosis of pre-capillary pulmonary hypertension in left heart disease